4Yeh J, Rein M, Nowak R. Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata[J]. Fertil Steril,1991, 56 (5) : 997-1000.
5Arici A, Sozen I. Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma[J]. Am J Obstet Gynecol,2003, 188 (1) : 76-83.
6Sozen I, Senturk LM, Arici A. Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus[J]. Fertil Steril,2001, 76 (4) :792-796.
7Lessl M, Klotzbuecher M, Schoen S, et al. Comparative messenger ribonucleic acid analysis of iediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium[J]. J Clin Endocrinol Metab,1997, 82 (8) : 2596-2600.
8Fujimoto J, Hori M, Ichigo S, et al. Tissue difference in the expression of mRNAs of Ha-ras, c-myc, fos and jun in human uterine endometrium, myotrium and leiomymas under the influence of estrogen/progesterone[J]. Tumor Biol, 1994, 15: 311-318.
9Shimomura Y, Matsuo H, Samoto T, et al. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma[J]. J Clin Endocrinol Metab,1998, 83 (6) : 2192-2198.
10Viville B, Charnock-Jones DS, Sharkey AM, et al. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium[J]. Hum Reprod, 1997, 12 (4) : 815-822.
4Chen W, Ohara N, Wang J, et al. A novel selective progesterone receptor modulator asoprisnil (1867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma ceils in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab, 2006, 91: 1296-1304.
5Fukuhara K, Kariya M, Kita M, et al. Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. J Clin Endocrinol Metab, 2002, 87: 1729-1736.
6Maruo T, Ohara N, Wang J, et al. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update, 2004, 10: 207-220.
7Zheng S J, Chen YH. TRAIL, Bim, and thymic-negative selection. Immunol Res, 2003, 28: 295-301.
8Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, et al. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol, 2003, 4: 255-260.
9Maruo T, Matsuo H, Shimomura Y, et al. Effects of progesterone on growth factor expression in human uterine leiomyoma. Steroids, 2003, 68: 817-824.
10Maruo T, Matsuo H, Samoto T, et al. Effects of progesterone on uterine leiomyoma growth and apoptosis. Steroids, 2000, 65: 585-592.
